These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 19530064

  • 1. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F, Palomba S, Vigorito C, Tafuri MG, Colao A, Lombardi G, Orio F.
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [Abstract] [Full Text] [Related]

  • 2. Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome?
    Corbould A.
    Diabetes Metab Res Rev; 2008 Oct; 24(7):520-32. PubMed ID: 18615851
    [Abstract] [Full Text] [Related]

  • 3. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A.
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [Abstract] [Full Text] [Related]

  • 4. Obesity and the polycystic ovary syndrome.
    Martínez-Bermejo E, Luque-Ramírez M, Escobar-Morreale HF.
    Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
    [Abstract] [Full Text] [Related]

  • 5. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E, Papavassiliou AG.
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [Abstract] [Full Text] [Related]

  • 6. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG, Patchava S, Laing I.
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [Abstract] [Full Text] [Related]

  • 7. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK, Tauchert S, Ortmann O, Diedrich K, Weiss JM.
    Ann Med; 2004 Dec; 36(6):426-39. PubMed ID: 15513294
    [Abstract] [Full Text] [Related]

  • 8. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E.
    Expert Rev Mol Med; 2008 Jan 30; 10():e3. PubMed ID: 18230193
    [Abstract] [Full Text] [Related]

  • 9. Androgen circle of polycystic ovary syndrome.
    Homburg R.
    Hum Reprod; 2009 Jul 30; 24(7):1548-55. PubMed ID: 19279033
    [Abstract] [Full Text] [Related]

  • 10. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F, Palomba S, Maresca L, Vuolo L, Tafuri D, Lombardi G, Colao A, Vigorito C, Francesco O.
    Clin Endocrinol (Oxf); 2008 Nov 30; 69(5):792-8. PubMed ID: 18505468
    [Abstract] [Full Text] [Related]

  • 11. Androgens and polycystic ovary syndrome.
    Nisenblat V, Norman RJ.
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun 30; 16(3):224-31. PubMed ID: 19390322
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular risk in women with polycystic ovary syndrome.
    Giallauria F, Orio F, Palomba S, Lombardi G, Colao A, Vigorito C.
    J Cardiovasc Med (Hagerstown); 2008 Oct 30; 9(10):987-92. PubMed ID: 18799960
    [Abstract] [Full Text] [Related]

  • 13. Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?
    Abbott DH, Barnett DK, Bruns CM, Dumesic DA.
    Hum Reprod Update; 2005 Oct 30; 11(4):357-74. PubMed ID: 15941725
    [Abstract] [Full Text] [Related]

  • 14. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC, Galluzzo A, Finocchiaro S, Criscimanna A, Giordano C.
    Clin Endocrinol (Oxf); 2008 Jul 30; 69(1):52-60. PubMed ID: 18034780
    [Abstract] [Full Text] [Related]

  • 15. Role of inositolphosphoglycan mediators of insulin action in the polycystic ovary syndrome.
    Nestler JE, Jakubowicz DJ, Iuorno MJ.
    J Pediatr Endocrinol Metab; 2000 Jul 30; 13 Suppl 5():1295-8. PubMed ID: 11117673
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insulin as an effector of human ovarian and adrenal steroid metabolism.
    Nestler JE, Strauss JF.
    Endocrinol Metab Clin North Am; 1991 Dec 30; 20(4):807-23. PubMed ID: 1778178
    [Abstract] [Full Text] [Related]

  • 18. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK, McCartney CR, Helm KD, Marshall JC.
    Semin Reprod Med; 2007 Sep 30; 25(5):352-9. PubMed ID: 17710731
    [Abstract] [Full Text] [Related]

  • 19. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome.
    Legro RS.
    J Pediatr Endocrinol Metab; 2002 Dec 30; 15 Suppl 5():1367-78. PubMed ID: 12510993
    [Abstract] [Full Text] [Related]

  • 20. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
    Otto-Buczkowska E, Jarosz-Chobot P, Deja G.
    Przegl Lek; 2006 Dec 30; 63(4):234-8. PubMed ID: 17080748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.